Enter assignee name

Trademarks = 4

Forward Citations = 3

Loading Chart...

8 inventors (with patents filed for the assignee):

John Lewis (5 out of 7 patents)

Roy Duncan (4 out of 6 patents)

Eileen Kathryn Clancy (3 out of 3 patents)

4. Roberto Justo De Antueno (3 out of 3 patents)

5. Rae-Lynn Nesbitt (3 out of 3 patents)

6. Konstantin Stoletov (2 out of 2 patents)

7. Lian Willetts (2 out of 2 patents)

8. Chungen Pan (1 out of 7 patents)

6 patents: Sort by Forward Citations

1. 12454557 - Recombinant polypeptides for membrane fusion and uses thereof (2025-10-28),

2. 12421514 - Methods for diagnosing and treating metastatic cancer (2025-09-23),

3. 12378289 - Recombinant oncolytic viruses for treatment of metastatic cancers (2025-08-05),

4. 11459362 - Recombinant polypepties for membrane fusion and uses thereof (2022-10-04),

5. 11236331 - Methods for diagnosing and treating metastatic cancer (2022-02-01),

6. 10227386 - Recombinant polypeptides for membrane fusion and uses thereof (2019-03-12),

Entos Pharmaceuticals Inc. is a biotechnology company focused on developing innovative therapies for various diseases. The company specializes in the use of its proprietary drug delivery platform, which enhances the efficacy and safety of therapeutic agents. With a commitment to advancing healthcare, Entos aims to address unmet medical needs through its research and development efforts. The team comprises experienced professionals dedicated to bringing transformative solutions to patients. Entos is actively engaged in collaborations and partnerships to accelerate the development of its product pipeline.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

6 Patents

#47 in Edmonton

#2,411 in Canada

Edmonton, Canada

Entos Pharmaceuticals Inc.